Satratoxin-G (SG) is the major macrocyclic trichothecene mycotoxin produced by Stachybotrys chartarum (atra) and has been implicated as a cause of a number of animal and human health problems including pulmonary hemorrhage in infants. However, there is little understanding where this toxin is localized in the spores and mycelial fragments of this species or in the lung impacted by SG-sequestered spores. The purpose of this study was to evaluate the distribution of SG in S. chartarum spores and mycelium in culture, and spore-impacted mouse lung in vivo, using immunocytochemistry. SG was localized predominately in S. chartarum spores with moderate labelling of the phialide-apex walls. Labelling was primarily along the outer plasmalemma surface and in the inner wall layer. Only modest labelling was observed in hyphae. Toxin localization at these sites supports the position that spores contain the highest satratoxin concentrations and that the toxin is constitutively produced. In impacted mouse lung, highest SG labelling was detected in lysosomes, along the inside of the nuclear membrane in nuclear heterochromatin and RER within alveolar macrophages. Alveolar type II cells also showed modest labelling of the nuclear heterochromatin and RER. There was no evidence that the toxin accumulated in the neutrophils, fibroblasts, or other cells associated with the granulomas surrounding spores or mycelial fragments. These observations indicate that SG displays a high degree of cellular specificity with respect to its uptake in mouse lung. They further indicate that the alveolar macrophages play an important role in the sequestration and immobilization of low concentrations of the toxin.
INTRODUCTION
Stachybotrys chartarum is an important environmental fungus often found in building environments supporting chronically wet, delignified cellulose substrates. It produces a variety of secondary metabolites and other compounds (Andersen et al., 2002; Nielsen et al., 1998; Jarvis et al., 1998) including spirocyclic drimanes (Ayer and Miao, 1993; Jarvis et al., 1995 Jarvis et al., , 1998 , trichoverroids (Croft et al., 1986) , the hemolytic protein stachylysin (Vesper et al., 2001) , and proteases (Kordula et al., 2002; Yike et al., 2002b) . Inhalation exposure to spores, mycelial fragments and dust, all containing toxins of this species, has been implicated as the cause of a number of animal and human health problems including pulmonary hemorrhage and hemosiderosis in infants Etzel and Dearborn, 1999) . Despite the fact that we have known for quite some time that toxins produced by this species can accumulate to relatively high concentrations in the conidia (Sorenson et al., 1987) and that spores and their toxins effect lung biology in vivo (Mason et al., 1998 Nikulin et al., 1996 Nikulin et al., , 1997 Rand et al., 2002 Rand et al., , 2003 , localization of the toxins in S. chartarum spore impacted lung has not been achieved until recently. Gregory et al. (2003) described the distribution of stachylysin, a hemolytic protein complex, in S. chartarum spores and spore impacted mouse and rat lung using immunohistochemistry and immunocyto-chemistry. They noted that stachylysin accumulated in lung in an apparently noncell-specific manner from highest concentrations around spores to no labelling in unaffected tissues.
Recently, one of us (J.P.) raised antibodies against satratoxin-G (SG). Satratoxin-G is a one of several macrocyclic trichothecene cytotoxins produced by this species (Jarvis et al., 1995) . Because exposure to this family of toxins in S. chartarum spores has been implicated in the onset of pulmonary hemorrhage and hemosiderosis in infants, we were interested in knowing whether this toxin accumulated in a nonspecific fashion in inflammatory tissue surrounding spores in the lungs or whether it was rapidly absorbed from the lungs, metabolized, and excreted as has been reported for the lipophilic trichothecene T-2 toxin (Pang et al., 1998) . The purpose of this study was to evaluate the distribution of SG in S. chartarum spores and mycelium grown in culture and in spore impacted mouse lungs using immunocytochemistry. Based on our previous work on stachylysin , we hypothesized that SG labelling would be concentrated at sites of spore impaction, especially in granulomas surrounding spores and exhibit a non-specific cellular gradient from highest labelling adjacent to the spore wall surfaces to little or no labelling in the unaffected lung.
MATERIALS AND METHODS

Conidia Collection:
The Stachybotrys chartarum isolate employed in this study was from Cleveland (Cleveland strain # 58-17 (=ATCC 201211) (supplied by D. Dearborn). Protein translation inhibition assay revealed this isolate to contain 670 fg satratoxin G (SG) equivalents/spore (Yike et al., 1999 (Yike et al., , 2002a while ELISA revealed it to contain Vol. 32, No. 1, 2004 SATRATOXIN IN STACHYBOTRYS CHARTARUM SPORES IN MOUSE LUNGS 27 980 fg SG equivalents/spore (Chung et al., 2003) . The isolate was cultured on Stachybotrys medium (LabCor, Seattle, Washington) for 3 weeks at 25 • C prior to instillation and immunocytochemistry. Primary (1 • ) Antibody (AB) Production: Satratoxin-G (SG) was prepared from cultures as described by Jarvis et al. (1995) and purified as described by Chung et al. (2003) . Antibodies were produced in rabbits against SG bis-hemisuccinate conjugated to BSA using procedures described by Chung et al. (2003) . For this, approximately 375 mg of BSA-SG conjugate in 1 ml PBS-Freunds complete adjuvant was injected intradermally into 3 rabbits, followed by a subcutaneous booster comprising BSA-SG conjugate (250 ug) in 1 ml PBS-Freund's incomplete adjuvant at week 18. The potency and performance of the antibodies were then tested in an enzyme-linked immunosorbent assay (ELISA). The dilution of purified antibody that produced an OD of 1.0 in the assay was 1/31250 (Chung et al., 2003) .
Specificity of Satratoxin G Antibody: The specificity of the rabbit SG antiserum was tested by using other macrocyclic trichothecenes, verrucarol, and DON, a nonmacrocyclic type B trichothecene, as competitors in the CD-ELISA as described by Chung at al. (2003) . Different macrocyclic trichothecenes exhibited cross-reactivity while verrucarol and DON did not cross-react with the antiserum. Concentrations at 50% inhibition (ID 50 ) of HRP-SG conjugate binding to antibodies on microtiter plates were 1.3, 5.4, 3.2, 25.1, and 52.5 ng/ml for satratoxin G, satratoxin H, iso-satratoxin F, roridin A, and verrucarin A, respectively. More than 1 pg/ml of verrucarol was required to inhibit 50% of HRP-SG conjugate binding. DON at 1 pg/ml did not inhibit binding of the SG-HRP.
Immunocytochemical Localization of Satratoxin G in S. chartarum Spores and Hyphae: To determine the distribution of SG in spores and hyphae, 3-week old cultures of S. chartarum were flooded using Trumps fixative (McDowell and Trump, 1976) , employing paraformaldehyde instead of formaldehyde, for immunocytochemistry. After 2 hr, at least 5 1-mm 3 pieces of medium supporting actively growing, sporulating fungus from each culture plate were randomly selected for TEM. After fixation, culture material was gently washed 2 × in 0.1 M phosphate buffer pH 7.6 for 1 hr each, dehydrated through an ascending ethanol series and embedded in LR White medium viscosity resin. Thin sections (silver to gold interference colors) were cut from at least 3 blocks of embedded material using a Reichert UM 2 Ultramicrotome. Sections were mounted onto #300 mesh gilded nickel grids.
Each prepared grid was assigned to 1 of 2 categories: control, or primary antibody (1 • AB), and then subjected to the following protocol: Sections on all grids were placed in a 20 ul 1: 1000 Proteinase K: Tris-HCl, pH 7.4 ((TBS) = 10 mM Tris-HCl pH 7.4, 150 mM NaCl, adjusted with dH 2 O to a final volume of 100 mL)) for 30 min at 37 • C. This was followed by 3 rinses in TBS, 5 min each. Grids were then incubated in a blocking buffer (1% (w/v) bovine serum albumin, or rabbit pre-immune serum, 0.02% sodium azide, 0.05% Tween 20, 100 mL TBS) for 15 min at room temperature. For detection of SG, grids assigned to 1 • AB treatment were incubated in a 1:1000 rabbit anti-satratoxin: blocking buffer solution for 1 hr at room temperature. Following incubation, all grids were rinsed 3× in Tris-buffered saline (TBS), 5 min each and excess TBS was removed by filter paper. They were then exposed to 1:100 goat anti-rabbit gold conjugate (15-nm diameter) (AB Cedarlane Laboratories Ltd): blocking buffer solution for 1 hr. Grids were then washed 3× in TBS (5 min each), followed by a 5-min rinse in ddH 2 O. Excess water was then removed and grids were then stained using 3% uranyl acetate (aqueous) for 10 min in the dark (Bozzola and Russell, 1992) . Grids assigned to control samples were treated as previously described except that either the primary antibody was omitted from the incubation solution, or pre-immune rabbit serum was used instead of primary antibody. Sections were then examined using a Hitachi 7500 Transmission Electron Microscope (TEM) at 5,000 to 70,000× magnifications and operated at 80 KV.
Intratracheal Instillations in vivo Mouse Model:
For these studies, 21-to 28-day-old, random-bred, Carworth Farms White (CFW), male mice, housed in accordance to the standards set forth by the Canadian Council for Animal Care (CCAC, 1993) and with the approval of the Saint Mary's University Animal Care Committee were used.
For instillation, 5 mice were anaesthetized via an intramuscular injection containing ketamine (Ketaleen) and xylazine (Rompun), as previously described (Mason et al., 1998) . Each mouse used for the study was inoculated intratracheally with 50 µl of S. chartarum spores, (1.4 × 10 6 spores/ml in physiological saline = 75,000 spores/animal = 3,000 spores/g BW) (Mason et al., 1998 . The mice were placed back into their cages immediately after instillation. During recovery, mice were continuously monitored for signs of sickness or distress, as outlined in the CCAC guidelines (CCAC, 1993) . Mice were sacrificed with a 300-µl intraperitoneal injection of sodium pentobarbital (65 mg/ml), 48 hr postinstillation. This time was used as our previous studies (see Rand et al., 2002 Rand et al., , 2003 have shown that some of the most pronounced changes in mouse lung bronchoalveolar lavage fluid (BALF) and tissue structure occur at this time. Once euthanized, each mouse was immediately weighed then placed ventral side up. The body cavity was opened and the abdominal artery severed for exsanguation. The chest cavity was then exposed and the lungs degassed by puncturing the pleural sac. The trachea was cannulated using an 18-gauge butterfly needle. The needle was connected by plastic tubing to a 30-ml syringe filled with a fixative mixture of 1.5% glutaraldehyde and 1.5% freshly prepared paraformaldehyde in 0.1 M cacodylate buffer (pH 7.35) (Bozzola and Russell, 1992) , for fixation by positive pressure instillation at 20 cm H 2 O as described by Rand et al. (2002a Rand et al. ( , 2002b for 30 min. After this time, the inflated lungs with instilled fixative were then carefully excised from the thoracic cavity in toto, disconnected from the catheter and placed into a 250-ml beaker filled with the fixative solution for 2 hr before processing for immunocytochemistry.
Histology: To determine whether lungs exposed to S. chartarum spores in this study showed signs typical of granulomatous inflammation reactions (see Rand et al., 2003) , the left lung lobe was excised, rinsed in tap water, dehydrated through an ascending ethanol series, cleared in xylene, embedded in paraffin, and sectioned at 4-µm thick. Sections were then mounted onto microscope slides and stained 28 GREGORY ET AL TOXICOLOGIC PATHOLOGY using Harris' hematoxylin and aqueous eosin (H&E) Humason (1976) .
Immunocytochemical Localization of SG In Vivo: For immunocytochemistry, the right cranial lung lobe from each animal was excised and cut into roughly 1-mm 3 sections. Sections were wet mounted and briefly inspected using stereomicroscopy to localize spores in lung samples. Tissues supporting spores were then excised, washed in the buffer, dehydrated through an ascending acetone series, and embedded in LR White for TEM. Thin sections (grey to silver interference colors) were cut from at least 3 blocks of embedded lung per animal using a Reichert UM 2 Ultramicrotome. Sections were mounted onto #300 mesh gilded nickel grids. Each grid was assigned to 1 of 2 categories and immuno-labelled as described previously and examined using the Hitachi 7500 TEM at 3,000-60,000× magnifications and operated at 80 KV.
RESULTS
Immunocytochemical Localization of Satratoxin G in S. chartarum Spores and Hyphae In Vitro: Heavy gold labelling was observed in spores of Stachybotrys chartarum. Gold label was clearly discerned from surrounding spore material as uniformly electron-opaque, spheroidal particles 15-nm wide. The inner wall layer (IW) of spores showed the heaviest labelling, especially along the outer plasmalemma surface (Fig. 1A) . Labelling of this membrane occurred as an almost linear array of gold particles that followed the contour of the outer plasmalemma surface (Fig. 1A insert) . Scattered labelling of the outer wall (OW) layer was observed, and in the growth medium surrounding spores. Reduced labelling was observed in phialide tip walls and in the growth medium surrounding these structures (Fig. 1B) . Only modest or no labelling was observed along the hyphal plasmalemma (Fig. 1C ). Control spores (Fig. 1D ) and mycelium did not label for SG (not shown).
Histology: Mouse lung exposed to S. chartarum spores showed typical early granulomatous reactions. Granulomas contained a pleomorphic inflammatory cell infiltrate that surrounded spores and spore fragments ( Fig. 2A) . Alveolar air spaces contained cellular debris, and alveolar macrophages (AMs) with ingested spores (Fig. 2B) .
Immunocytochemical Localization of Satratoxin-G in Spores In Vivo: Low magnification TEM (=2000 × magnifications) revealed that the spores were surrounded by neutrophils and AMs (Fig. 3A) , and the occasional eosinophil (not shown). Solitary spores (Fig. 3A) and spore fragments (Figs. 3A, 4A , 4B) were also engulfed in AMs.
As in the in vitro labelling experiment, heavy gold labelling was observed in the IW with reduced labelling in the OW of the phagocytized spore (Fig. 4B) . Labelling was not observed in the extracellular space, in neutrophils in mouse lung granulomas immediately surrounding spores, or in eosinophils. AMs with ingested spores and wall fragments in phagolysosomes (PL) were noticeably labelled. Heaviest labelling was in lysosomes and residual bodies (Figs. 3B, 3C, 4A) with reduced labelling on nuclear heterochromatin along the inside of the nuclear membrane (Fig. 4A ). Moderate AM labelling was noted on the rough endoplasmic reticulum (RER) (Figs. 3B, 4B ). Modest alveolar type II cell labelling was also detected. These cells, which are distinguished by the microvilli on their luminal surface, their lamellar bodies, and their proximally positioned nucleus, showed nuclear membrane and nuclear heterochromatin labelling (Fig. 4C) , and labelling along RER and the plasmalemma (Fig. 4D ). However, there was no evidence of alveolar type II cell microvilli (Fig. 4D ) or lamellar body labelling (not shown). Control sections did not label for satratoxin ( Fig. 3D ).
DISCUSSION
It is clear from protein translation inhibition (Yike et al., 1999 (Yike et al., , 2002a and ELISA assays (Chung et al., 2003) that the S. chartarum isolate used in this study produces the trichothecene satratoxin G (SG). However, neither of these assays indicate where the toxin is distributed in fungal spores or mycelium. As far as we are aware, this is the first study that demonstrates the distribution of SG in a satratoxin producing Stachybotrys chartarum isolate grown in vitro, and in spore impacted mouse lung in vivo using immunocytochemistry.
Results of this study have revealed that SG is distributed primarily in spores followed by the phialides and hyphae, respectively. In spores the toxin is distribution primarily along the outer plasmalemma surface and in the inner wall layer (IW), with less in the outer wall layer (OW). This distribution in the spores is somewhat similar to that reported for stachylysin in spore and mycelial walls of a stachylysin producing S. chartarum isolate . An exception is that SG labelling excluded spore cytoplasm, which labelled for stachylysin. The SG label distribution pattern observed herein suggests that the spore wall layer represents a satratoxin diffusion gradient and that SG accumulating in the IW diffuses outward into material matrix surrounding the fungal wall. Finding SG primarily along the outer plasmalemma surface and in the spore walls, with virtually none in the cytoplasm, suggests that SG is constitutively expressed in the cytoplasm, and then exported over the plasmalemma into the wall as the active metabolite. This is consistent with what is known about macrocyclic trichothecene synthesis, which first involves the formation of trichodiene through the cyclization of trans, trans-farnesyl Ppi by trichodiene synthase (Straus et al., 1999) followed by export to the outer cell environment. The observation that the heaviest labelling was in the spores is also consistent with the results of Sorenson et al. (1987) and Yike et al. (2002a) that showed highest concentrations of satratoxin G and satratoxin H in spores of certain S. chartarum strains. That moderate labelling was observed in phialide walls also indicates that this structure has toxicologic potency, although less than that of the spores.
Histology revealed that exposure to S. chartarum spores results in an inflammatory reaction including granuloma formation. This result is similar to that of other studies that have shown intratracheal or intranasal installation of Stachybotrys spores in rodents can result in massive lung damage in both mice (Nikulin et al., 1996 (Nikulin et al., , 1997 Rand et al., 2003) and rats (Yike et al., 2002a) .
The fact that we observed labelling of cells associated with mouse lung granulomas surrounding spores indicates in vivo that SG binding had occurred. This was not surprising. Vol. 32, No. 1, 2004 . Note labelling (arrows) in walls and in the space outside the phialide. OW = outer spore wall layer; IW = internal spore wall layer. Bar = 0.5 µm. (C) Immunocytochemical labelling of SG in cultured Stachybotrys chartarum (58-17) hypha. Note the lack of labelling along the plasmalemma (arrows). ow = outer spore wall layer; iw = internal spore wall layer. Bar = 0.5 µm. (D) Immunocytochemical control showing lack of SG labelling in Stachybotrys chartarum spore. Note the lack of labelling along the plasmalemma (arrows). ow = outer spore wall layer; iw = internal spore wall layer. Bar = 1.0 µm.
Both in vitro and in vivo studies have revealed that exposure to either pure or spore sequestered macrocyclic trichothecenes (e.g., satratoxins, roridins, and verrucarins) affect a variety of cell functions and biochemical pathways including depressed macrophage activity (Plasencia and Rosenstein, 1990; Sorenson et al., 1987) and inflammatory response (Routsalainen et al., 1998) , alteration of surfactant production in alveolar type II cells (MaCrae et al., 2001 , Mason et al., 1998 and in lung tissue , micro-anatomical changes in lung alveolar type II cells TOXICOLOGIC PATHOLOGY FIGURE 2.-(A) H&E stained mouse lung granuloma showing pleomorphic cell infiltrate surrounding Stachybotrys chartarum spores and spore fragments (arrows). Bar = 25 µm. (B) H&E stained mouse lung granuloma from a Stachybotrys chartarum spore exposed animal. Note S. chartarum spores in alveolar macrophages (arrows), and alveolar spaces (a) filled with cells and cellular debris. Bar = 25 µm. (Rand et al., 2002a) , membrane damage (Peltola et al., 1999) and aptoptosis (Okumura et al., 1999; Yang et al., 2000) . It is also well understood that trichothecenes interact with cell membranes and cause their disfunction (Pertola et al., 1999; Riley and Norred, 1996) . These studies suggest that the trichothecenes compromise a wide range of cellular activities in numerous cell types. This view is consistent with results of studies with radiolabeled trichothecene mycotoxins that show that the toxin interaction with cells is best viewed as a free, bidirectional movement of these low-molecular-weight chemicals across the plasma membrane; followed by specific, high-affinity binding to ribosomes (Middlebrook and Leatherman, 1989) , and binding to DNA and RNA. In the in vitro studies, trichothecene-induced inhibition of protein synthesis is considered to be the primary biochemical lesion, whereas inhibition of RNA and DNA synthesis are considered to be secondary effects (Ueno, 1983) . While it is clear that trichothecenes are toxic and affect a wide variety of cell types by altering biochemical and DNA and RNA synthesis pathways (Thompson and Wannemacher, 1990) , the observation that SG labelling was associated mostly with alveolar macrophages (AMs) and generally not with other cells surrounding spores in granulomatous tissue was therefore surprising. Lack of labelling in other granuloma cells could be due in part to the 48-hr time point chosen in our study. However, the labelling of lysosomes in AMs may be significant in explaining this observation.
It is clear that AMs play a central role in lung defence by their ability to phagocytize particulates and macromolecular debris, among others (see review by Bezdicek and Crystal, 1997) . Results of studies by Gregory et al. (2003) clearly show that stachylysin-labelled S. chartarum spore fragments are phagocytized by mouse alveolar macrophages and that these cells play a role in defence against exposure to this haemolytic protein. Moreover, AMs also detoxify xenobiotics (Buchwald, 2001) . Detoxification within the mammalian macrophage is achieved by a variety of lysosomal enzymes, including carboxylesterase (Buchwald, 2001) . While it is unknown whether mouse AMs contain trichothecene-specific carboxylesterase, trichothecenespecific carboxylesterase activity has been detected in brain, kidney, spleen, intestine, erythrocytes, and in white blood cells (Wannemacher and Weiner, 1997) . Okamoto et al. (1998) reported that nonspecific carboxylesterase was present in macrophages in a species-specific amount. It was strongly present in mice, but weak in dogs and cats. A microsomal, nonspecific carboxylesterase [EC 3.1.1.1] from liver is known to selectively hydrolyse the C-4 acetyl group of T-2 toxin to yield HT-2 toxin (Johnsen et al., 1986; Yoshizawa et al., 1984) . Deoxygenation of the epoxide group yields deepoxy metabolites, which are essentially nontoxic (Swanson et al., 1988) . As AM lysosomes contain carboxylesterase, sequestration of SG in these organelles may represent an important process whereby macrocyclic trichothecene detoxification can be achieved. However, if there is more trichothecene than can be dealt with by the macrophage carboxylesterase, necrotic or apoptotic cell changes resulting in death may occur. This may explain why macrocyclic trichothecenes are so highly toxic to macrophages in vitro . Moreover, overexposure to SG may also explain why SG was observed on RER and nuclear chromatin in some AMs, and on the plasmalemma, RER and nuclear chromatin in some alveolar type II cells observed in the present study. An important result of the study was finding SG labelling of alveolar type II cells. This observation further supports our earlier studies which have shown that these cells are sensitive to S. chartarum spore and isosatratoxin-F exposures (Hastings et al., 2003; MaCrae et al., 2001; Mason et al., 1998 Mason et al., , 2001 Rand et al., 2002; Sumarah et al., 1999) . Sensitivity to S. chartarum spore and isosatratoxin-F exposures is manifest as significant changes in the phospholipid composition of pulmonary surfactant in bronchoalveolar lavage fluid (BALF), changes in regulation of both secretion and 32 GREGORY ET AL TOXICOLOGIC PATHOLOGY synthesis of pulmonary surfactant, in the pattern of phospholipid targeting to the pulmonary surfactant pools in mice, and in alveolar type II cell microanatomy. It is unclear why labelling was confined to the alveolar type II cell nuclear membrane, heterochromatin, RER and plasmalemma. However, binding at these sites may explain some of the biochemical changes in surfactant composition and cycling associated cells exposed to S. chartarum spores and toxins. 
